Why did you start this company?
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
What specific need/problem are you seeking to address in healthcare?
“NeuroFlow’s overarching goal is to provide a standard of care for mental health. The technology helps clinicians to diagnose, treat, and measure patients more efficiently by leveraging data and telehealth. With compliance, patients can get on the path to better health sooner.”
What does your product do? How does it work?
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
“NeuroFlow has developed two products: EngageBH™ and IntegrateHealth™. Although the platform has several applications across healthcare settings, its main objective is to connect clinicians and their patients in real-time, using data and monitoring functions to improve patient outcomes. It is both mobile- and web-based, in private practices and major health systems.”
Is this your first healthcare startup? What’s your background in healthcare?
“This is my second startup venture, but first in healthcare. After completing a research project at the University of Pennsylvania’s Neuroscience Department, I began applying business acumen to solving the broad challenges associated with mental health care.”
What is your company’s business model?
“NeuroFlow is selling IntegrateHealth™ to two key buyers: primary care/pain management clinics and enterprise systems, while EngageBH™ is geared towards mental health clinicians. Clients pay based on volume of users (a tier model) and can subscribe as an individual or for a larger body of professionals. The company’s largest engagement is with 300 clinicians.”
Who is your customer? How do you generate revenue?
“Customers fall into one of three buckets: mental health clinics, primary care/pain management clinics and large-scale health systems. As mentioned above, it’s a tier system based on total number of users. Clients can roll-out the platform with a population of clinicians ‘on board’ and expand to meet additional demand.”
Do you have clinical validation for your product?
“NeuroFlow is certified by the Smart Health Innovation Lab, a joint accelerator between Aspire Ventures, Capital Blue Cross, and Penn Medicine Lancaster General Hospital. The 12-week program allowed NeuroFlow to beta test a product in several stages of the healthcare ecosystem, validating it with real users. Once completed, the technology was approved to officially “launch” within the major health system. The platform is also currently being validated in the Philadelphia VA through funding from the National Science Foundation.”
